Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinib. (Q54646694)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinib. |
scientific article |
Statements
Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinib. (English)
1 reference
Siraj M Ali
1 reference
R Kathy Alpaugh
1 reference
Jamie K Buell
1 reference
Philip J Stephens
1 reference
Jian Qin Michael Yu
1 reference
Hong Wu
1 reference
Christine N Hiemstra
1 reference
Vincent A Miller
1 reference
Doron Lipson
1 reference
Gary A Palmer
1 reference
Jeffrey S Ross
1 reference
Massimo Cristofanilli
1 reference
27 September 2013
1 reference
14
1 reference
e14-6
1 reference
1
1 reference
Identifiers
1 reference